Key Events This Week
Feb 9: Stock opens at Rs.2,000.95, up 0.75%
Feb 10: New 52-week high at Rs.2,120 and all-time high at Rs.2,056.35
Feb 11: Minor correction with a 0.99% decline
Feb 12: Strong rebound with a 3.18% gain
Feb 13: Week closes at Rs.2,016.25, down 3.76% on the day
Monday, 9 February 2026: Steady Start Amid Broad Market Gains
Acutaas Chemicals commenced the week at Rs.2,000.95, registering a 0.75% increase from the previous Friday’s close of Rs.1,986.00. This rise was in line with the broader market, as the Sensex advanced 1.04% to close at 37,113.23. The stock’s volume was robust at 182,978 shares, signalling healthy investor interest. The positive start set the tone for the week, supported by the company’s strong fundamentals and recent upgrades.
Tuesday, 10 February 2026: Breakthrough with New 52-Week and All-Time Highs
Tuesday marked a pivotal day for Acutaas Chemicals as the stock surged to a new 52-week high of Rs.2,120 and an all-time high intraday price of Rs.2,056.35. The stock closed at Rs.2,050.60, up 2.48% on the day, significantly outperforming the Sensex’s modest 0.25% gain. This rally was driven by the company’s sustained earnings growth, operational efficiency, and strong institutional backing, which have been highlighted in recent financial disclosures.
The stock’s performance outpaced the Pharmaceuticals & Biotechnology sector by nearly 4%, reflecting its leadership within the industry. Trading volumes, however, dropped sharply to 28,043 shares, indicating some profit booking after the sharp rise. The stock’s technical position remained strong, trading above all key moving averages, signalling continued bullish momentum.
Wednesday, 11 February 2026: Minor Pullback on Lower Volumes
Following the previous day’s gains, Acutaas Chemicals experienced a slight correction, closing at Rs.2,030.40, down 0.99%. The decline came amid subdued volume of 24,436 shares and a Sensex gain of 0.13%. This minor pullback was a natural consolidation after the sharp advance, with the stock maintaining its position above critical support levels. The correction did not materially alter the stock’s positive technical outlook or fundamental story.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Thursday, 12 February 2026: Strong Rebound Despite Sensex Decline
Acutaas Chemicals rebounded strongly on Thursday, gaining 3.18% to close at Rs.2,095.00. This recovery was notable as the Sensex declined 0.56% on the day, closing at 37,049.40. The stock’s volume was relatively low at 12,209 shares, suggesting selective buying interest. The rebound reinforced the stock’s resilience and underlying strength, supported by its robust financial metrics including a 21.30% ROCE and consistent profit growth.
Friday, 13 February 2026: Profit Taking Leads to Sharp Decline
The week concluded with a sharp decline of 3.76%, as Acutaas Chemicals closed at Rs.2,016.25 on Friday. This drop contrasted with the Sensex’s larger fall of 1.40%, closing at 36,532.48. The stock’s volume surged to 34,899 shares, indicating significant selling pressure likely due to profit booking after the week’s earlier gains and milestone highs. Despite the decline, the stock ended the week with a positive 1.52% gain from the previous Friday’s close, outperforming the Sensex’s 0.54% loss.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.2,000.95 | +0.75% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.2,050.60 | +2.48% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.2,030.40 | -0.99% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.2,095.00 | +3.18% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.2,016.25 | -3.76% | 36,532.48 | -1.40% |
Key Takeaways from the Week
The week’s price action for Acutaas Chemicals was characterised by strong upward momentum early in the week, culminating in new 52-week and all-time highs on 10 February. This rally was supported by the company’s impressive financial performance, including a 47.82% net profit growth in the latest quarter and a robust ROCE of 21.30%. Institutional ownership remains significant at 38.38%, underscoring confidence from major market participants.
Despite the strong fundamentals, the stock experienced volatility with a midweek correction and a sharp decline on Friday, likely reflecting profit-taking after the recent gains. The stock’s valuation metrics, including a price-to-book ratio of 11.6 and a PEG ratio of 0.4, suggest that earnings growth has outpaced price appreciation, indicating potential value for investors focused on fundamentals.
Relative to the Sensex, Acutaas Chemicals outperformed consistently, gaining 1.52% over the week while the benchmark index declined by 0.54%. This outperformance highlights the stock’s resilience amid broader market weakness and its leadership within the Pharmaceuticals & Biotechnology sector.
Want to dive deeper on Acutaas Chemicals Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Conclusion: Sustained Momentum Despite Volatility
Acutaas Chemicals Ltd demonstrated a resilient performance during the week of 9 to 13 February 2026, highlighted by record-setting price levels and solid fundamental backing. The stock’s ability to outperform the Sensex amid mixed market conditions reflects its strong operational metrics and investor confidence. While the late-week pullback introduced some volatility, the overall weekly gain of 1.52% confirms the stock’s positive trajectory.
With a strong Mojo Score of 82.0 and a recent upgrade to a Strong Buy rating, Acutaas Chemicals remains a notable presence in the small-cap segment. Investors monitoring the stock should consider both its robust earnings growth and the potential for short-term price fluctuations as part of their analysis.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
